Compare RXO & NVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RXO | NVST |
|---|---|---|
| Founded | 2022 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 4.6B |
| IPO Year | 2022 | 2019 |
| Metric | RXO | NVST |
|---|---|---|
| Price | $23.45 | $28.02 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 13 |
| Target Price | $16.33 | ★ $26.46 |
| AVG Volume (30 Days) | 2.1M | ★ 3.0M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 72.81 | ★ 104.31 |
| EPS | N/A | ★ 0.56 |
| Revenue | ★ $5,742,000,000.00 | $2,566,500,000.00 |
| Revenue This Year | $0.49 | $6.67 |
| Revenue Next Year | $6.90 | $3.55 |
| P/E Ratio | ★ N/A | $50.13 |
| Revenue Growth | ★ 26.20 | N/A |
| 52 Week Low | $10.43 | $18.77 |
| 52 Week High | $29.90 | $30.42 |
| Indicator | RXO | NVST |
|---|---|---|
| Relative Strength Index (RSI) | 49.12 | 57.25 |
| Support Level | $11.40 | $27.96 |
| Resistance Level | $29.46 | $29.21 |
| Average True Range (ATR) | 1.44 | 0.96 |
| MACD | 0.20 | 0.01 |
| Stochastic Oscillator | 90.56 | 66.59 |
RXO Inc is a brokered transportation platform defined by technology and a nimble, asset-light business model, with the component being core truck brokerage business. Its operations also include three asset-light, brokered transportation services, all of which complement its truck brokerage business: managed transportation, last mile and freight forwarding. The company operates into one reportable segment. The operates within the transportation industry and in the same geography North America.
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.